📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor. (2014)

First Author: England KS

Attributed to: EPSRC-Royal Society fellowship engagement (2012): Development of Chemical Tools for Probing Histone Demethylases funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/c4md00291a

PubMed Identifier: 26682034

Publication URI: http://europepmc.org/abstract/MED/26682034

Type: Journal Article/Review

Volume: 5

Parent Publication: MedChemComm

Issue: 12

ISSN: 2040-2503